Skip to content

US · MMS · SPECIALTY BUSINESS SERVICES

Maximus, Inc. (MMS) intrinsic value and stock valuation

$62.79as of 2026-11-21 · Mkt cap 3.32B

Data updated · price as of 2026-11-21

UndervaluedIC value is 20–50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Maximus, Inc. DCF and intrinsic value

InvestorsCraft values MMS with the Chepakovich two-stage DCF model — currently rated undervalued. How the model works · Run your own DCF prefilled from MMS’s statements →

Maximus, Inc. Graham Number

Graham Number: $60.38d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Industrials · Specialty Business Services McLean, VA 22102 maximus.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$5.43B+9.4% 5y CAGRd
20112025
Net income
$319M+8.3% 5y CAGRd
20112025
Free cash flow
$366.2M+12.4% 5y CAGRd
20112025
Total equity
$1.67B+6.2% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$5.43B$5.31B$4.9B$4.63B$4.25B
Operating income$576.8M$491.7M$295.4M$311.8M$419.4M
Net income$319M$306.9M$161.8M$203.8M$291.2M
EPSd$5.51M$4.99M$2.63M$3.29M$4.67M
Operating cash flow$429.4M$515.3M$314.3M$289.8M$517.3M
Capital expenditure-$-63.21M-$-114.19M-$-90.69M-$-56.15M-$-36.56M
Free cash flow$366.2M$401.1M$223.7M$233.7M$480.8M
Total assets$4.07B$4.13B$3.99B$3.99B$4.12B
Total debt$1.44B$1.28B$1.43B$1.51B$1.71B
Net debt$1.18B$1.04B$1.31B$1.37B$1.55B
Total equity$1.67B$1.84B$1.67B$1.55B$1.48B
Cash and short-term investments$260.5M$235.8M$122.1M$136.8M$156.6M
Income statement
20252024202320222021
Revenue$5.43B$5.31B$4.9B$4.63B$4.25B
Cost of revenue$4.19B$4.15B$3.97B$3.78B$3.35B
Gross profit$1.25B$1.16B$934M$849.4M$902.6M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$673.1M$668.4M$638.7M$537.6M$483.3M
Other expenses$0.00$0.00$0.00$0.00$0.00
Operating expenses$673.1M$668.4M$638.7M$537.6M$483.3M
Cost and expenses$4.85B$4.81B$4.61B$4.32B$3.84B
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$84.1M$82.4M$84.1M$46M$14.7M
Depreciation and amortization$145.8M$135.3M$162M$141.7M$104.3M
Ebitda$674.8M$624.3M$456.5M$464.8M$502.7M
Operating income$576.8M$491.7M$295.4M$311.8M$419.4M
Total other income/expenses, net-$-131.9M-$-85.21M-$-85.08M-$-34.69M-$-35.67M
Income before tax$444.9M$406.5M$210.3M$277.1M$383.7M
Income tax expense$125.8M$99.6M$48.5M$73.3M$92.5M
Net income$319M$306.9M$161.8M$203.8M$291.2M
Weighted average shares outstanding$57.4M$61.1M$61.1M$61.8M$62.1M
Weighted average diluted shares outstanding$57.9M$61.5M$61.5M$62M$62.4M
Balance sheet
20252024202320222021
Cash and short-term investments$260.5M$235.8M$122.1M$136.8M$156.6M
Net receivables$902M$884.8M$843.4M$809.3M$840.2M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$1.25B$1.2B$1.06B$1.03B$1.08B
Property, plant and equipment, net$131.5M$172.6M$202.8M$185.1M$242M
Goodwill and intangible assets$2.53B$2.6B$2.59B$2.64B$2.7B
Long-term investments$5.5M$12.6M$31.4M$31.4M$0.00
Total non-current assets$2.82B$2.93B$2.93B$2.96B$3.04B
Total assets$4.07B$4.13B$3.99B$3.99B$4.12B
Accounts payable$296.9M$303.3M$282.1M$264.6M$305.6M
Short-term debt$91.3M$87.8M$136.7M$127.5M$156.6M
Deferred revenue$53.8M$83.2M$60.5M$87.2M$98.6M
Total current liabilities$765.2M$807.5M$723M$774.5M$789.4M
Long-term debt$1.35B$1.19B$1.29B$1.38B$1.55B
Deferred revenue, non-current$43.8M$45.1M$38.9M$21.4M$35.9M
Total non-current liabilities$1.63B$1.48B$1.59B$1.67B$1.85B
Capital lease obligations$71.3M$97.2M$129.4M$86.2M$121.8M
Total liabilities$2.4B$2.29B$2.32B$2.44B$2.64B
Common stock$628.1M$598.3M$577.9M$558M$532.4M
Retained earnings$1.06B$1.28B$1.12B$1.03B$987.8M
Accumulated other comprehensive income (loss)-$-17.87M-$-32.46M-$-27.61M-$-33.96M-$-39.91M
Total equity$1.67B$1.84B$1.67B$1.55B$1.48B
Total investments$5.5M$12.6M$31.4M$31.4M$0.00
Total debt$1.44B$1.28B$1.43B$1.51B$1.71B
Net debt$1.18B$1.04B$1.31B$1.37B$1.55B
Cash flow statement
20252024202320222021
Net income$319M$306.9M$161.8M$203.8M$291.2M
Depreciation and amortization$133.7M$125.5M$149.3M$132.8M$90.7M
Stock-based compensation$41.2M$35.4M$29.5M$30.5M$28.6M
Change in working capital-$-90.17M$78.9M-$-31.56M-$-79.43M$104.1M
Accounts receivable-$-31.85M-$-50.56M-$-23.4M$14.1M$38.6M
Inventory$0.00$0.00$860K$0.00-$-26.9M
Accounts payable-$-7.49M$18.3M$17.7M-$-32.72M$26.9M
Net cash provided by operating activities$429.4M$515.3M$314.3M$289.8M$517.3M
Investments in property, plant and equipment-$-63.21M-$-114.19M-$-90.69M-$-56.15M-$-36.56M
Acquisitions, net$0.00$3.08M$9.73M-$-14.29M-$-1.8B
Net cash used for investing activities-$-60.26M-$-129.1M-$-80.96M-$-54.01M-$-1.84B
Common stock issued$0.00$0.00$0.00$0.00$0.00
Common stock repurchased-$-447.48M-$-73.07M-$-8.47M-$-96.12M-$-3.36M
Dividends paid-$-68.71M-$-72.9M-$-68.07M-$-68.72M-$-68.84M
Net cash used for financing activities-$-343.88M-$-275.65M-$-250.8M-$-248.27M$1.39B
Net change in cash$24.7M$113.7M-$-14.7M-$-19.77M$68M
Cash at end of period$260.5M$235.8M$122.1M$136.8M$156.6M
Operating cash flow$429.4M$515.3M$314.3M$289.8M$517.3M
Capital expenditure-$-63.21M-$-114.19M-$-90.69M-$-56.15M-$-36.56M
Free cash flow$366.2M$401.1M$223.7M$233.7M$480.8M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Maximus, Inc.

        Maximus, Inc. specializes in delivering business process services (BPS) tailored for governmental health and human welfare initiatives. Its operations are structured into three main divisions: U.S. Services, U.S. Federal Services, and International Services. The U.S. Services division delivers a wide array of BPS solutions to state and local government programs across the United States. These offerings encompass program administration, handling appeals and evaluations, and providing specialized consulting. Key programs supported include the Affordable Care Act, Medicaid, the Children's Health Insurance Program, Temporary Assistance to Needy Families, and child support initiatives, alongside Preadmission Screening and Resident Reviews and Independent Developmental Disability assessments. Furthermore, this segment facilitates program eligibility and enrollment, operates centralized multilingual contact centers with multichannel and digital self-service capabilities, offers application assistance and impartial health plan selection guidance, and conducts outreach, education, eligibility determination, enrollment, and redetermination for beneficiaries. It also performs person-centered independent assessments for disability, long-term illness, and other health conditions, complemented by targeted consulting services. The U.S. Federal Services segment focuses on providing critical support to federal government agencies. Its services include establishing and managing centralized citizen engagement centers, overseeing document and record management, offering case management and direct citizen support, and delivering consumer education. This division also handles independent medical reviews, appeals for worker's compensation benefits, Medicare and Medicaid appeals, and eligibility appeals for the federal marketplace. Additionally, it contributes to the modernization of systems and IT infrastructure, provides operational support for infrastructure, offers software development, operations, and management, and specializes in data analytics. Internationally, the company's "Outside the U.S." segment delivers BPS offerings to both governmental bodies and commercial enterprises. These services include health and disability evaluations, the administration of employment programs, and various other services aimed at assisting job seekers. Established in 1975, Maximus, Inc. maintains its corporate headquarters in Tysons, Virginia.

        CEO
        Bruce L. Caswell
        Employees
        37.2K
        Beta
        0.60

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of Maximus, Inc. (MMS)?

        Maximus, Inc. (MMS) is currently undervalued based on the InvestorsCraft IC model — IC value is 20–50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is MMS undervalued?

        MMS trades at a price of $62.79 (Nov 21, 2026): undervalued — IC value is 20–50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.